en
Scientific article
English

Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial

Published inTransplantation, vol. 98, no. 12, p. 1301-1309
Publication date2014
Abstract

Our final objective is to develop an adoptive therapy with tolerogenic donor-specific type 1 T regulatory cells for patients with type 1 diabetes undergoing islet transplantation. The achievement of this objective depends on the availability of an immunosuppressive treatment compatible with the survival, function, and expansion of type 1 T regulatory cells.

Citation (ISO format)
MAFFI, Paola et al. Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial. In: Transplantation, 2014, vol. 98, n° 12, p. 1301–1309. doi: 10.1097/TP.0000000000000396
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0041-1337
479views
0downloads

Technical informations

Creation05/13/2015 2:27:00 PM
First validation05/13/2015 2:27:00 PM
Update time03/14/2023 11:18:11 PM
Status update03/14/2023 11:18:11 PM
Last indexation01/16/2024 6:02:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack